|
TTC35 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.81860090822761E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.95219995724472E-09 |
| Normal-vs-Stage2 |
8.60959999959832E-07 |
| Normal-vs-Stage3 |
2.06640038413752E-10 |
| Normal-vs-Stage4 |
2.05550000353938E-08 |
| Stage1-vs-Stage2 |
4.112200E-01 |
| Stage1-vs-Stage3 |
7.127600E-02 |
| Stage1-vs-Stage4 |
2.941600E-01 |
| Stage2-vs-Stage3 |
6.661400E-01 |
| Stage2-vs-Stage4 |
8.952000E-01 |
| Stage3-vs-Stage4 |
7.557400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.4856119646729E-13 |
| Normal-vs-AfricanAmerican |
1.104300E-03 |
| Normal-vs-Asian |
1.77917999999444E-05 |
| Caucasian-vs-AfricanAmerican |
1.398960E-01 |
| Caucasian-vs-Asian |
2.293200E-01 |
| AfricanAmerican-vs-Asian |
6.322800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.66164909293821E-13 |
| Normal-vs-Female |
1.8229000531278E-09 |
| Male-vs-Female |
2.646100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.90819999696035E-08 |
| Normal-vs-Age(41-60Yrs) |
6.29960528186757E-11 |
| Normal-vs-Age(61-80Yrs) |
1.91310001174116E-09 |
| Normal-vs-Age(81-100Yrs) |
1.440520E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.732600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.868200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.640600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.603400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.835800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.897600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.507800E-01 |
| Classical-VS-Follicular |
2.906400E-01 |
| Classical-VS-Other |
4.538600E-01 |
| Classical-VS-Normal |
3.14959169855911E-12 |
| Tall-VS-Follicular |
5.475400E-01 |
| Tall-VS-Other |
4.532800E-01 |
| Tall-VS-Normal |
2.07139999999217E-05 |
| Follicular-VS-Other |
4.149200E-01 |
| Follicular-VS-Normal |
4.49540000000415E-05 |
| Other-VS-Normal |
1.396870E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.99789995658506E-09 |
| Normal-vs-N1 |
2.28490000253601E-08 |
| N0-vs-N1 |
3.981000E-01 |
|
|
